Hematology/Oncology News

Adults with obesity who underwent bariatric surgery were less likely to develop pancreatic cancer than those who with obesity who did not have bariatric surgery, researchers reported.

In a video exclusive, Craig Munroe, MD, discusses how recent revisions to quality indicators for colonoscopy from ACG and ASGE may improve patient outcomes by raising the standards of the procedure.

Most cancer clinical trials use inaccurate tests to evaluate kidney function when determining participant eligibility, according to results of a cross-sectional study.

Self-identifying transgender individuals assigned female at birth face three key barriers when seeking care for breast or gynecologic cancers, according to results of a qualitative study published in JAMA Network Open.

Young adults with cancer who were eligible for the Affordable Care Act’s dependent care expansion had greatly improved survival times during the first decade of the ACA, an analysis in Cancer showed.

In this video, Nisha Joseph, MD, an associate professor in the Department of Hematology and Medical Oncology at Emory University School of Medicine, discusses how she approaches putting together a treatment plan for a patient with multiple myeloma.

In this video, Nisha Joseph, MD, an associate professor in the Department of Hematology and Medical Oncology at Emory University School of Medicine, discusses how multiple myeloma awareness can be increased among the general public.

In this video, Nisha Joseph, MD, an associate professor in the Department of Hematology and Medical Oncology at Emory University School of Medicine, discusses the major areas of unmet need in multiple myeloma treatment.

In this video, Nisha Joseph, MD, an associate professor in the Department of Hematology and Medical Oncology at Emory University School of Medicine, discusses some of the new treatments in the pipeline for multiple myeloma.

In this video, Nisha Joseph, MD, an associate professor in the Department of Hematology and Medical Oncology at Emory University School of Medicine, discusses the mysteries still surrounding who is most likely to develop multiple myeloma.